Wednesday, May 18, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | Anti Diabetic Drug Proposed For Covid Treatment

Anti-diabetic drug proposed for Covid treatment

By Telangana Today
Published: Published Date - 08:34 PM, Thu - 1 July 21

Hyderabad: Research by ReaGene Innovations Private Limited, a startup incubated at the ASPIRE-BioNEST, and INDRAS Private Limited suggests that an anti-diabetic drug Ertugliflozin, can be repurposed to treat Covid-19.

According to the findings, the repurposed drug binds effectively to the receptor binding domain of the spike protein of Covid-19 and also displayed significant anti-inflammatory and antithrombotic properties in a 3D human lung model.

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes and acts against diabetes by removing excessive glucose through urine. “It has immense potential to treat Covid-19 infection and our research proved its efficacy in test-tube assays,” said Dr Uday Saxena, CEO, ReaGene Innovations.

This research, funded by IT giant Tech Mahindra, was done by a team led by Dr Ratnakar Palakodeti, Global Practice Head of Life Sciences and Nikhil Malhotra, Global Head, Makers Lab in the scientific partnership of INDRAS and ReaGene. The outcome of the research was recently published in a journal and a patent was also filed for the same. “We have found a molecule that can potentially attack corona virus. We have applied for a joint patent,” said Malhotra.

ASPIRE-BioNEST is a life sciences incubator jointly funded by BIRAC, a not-for-profit organisation of Department of Biotechnology, Government of India and University of Hyderabad, and incubates startups like ReaGene, helping them achieve their goals by providing plug-and-play facilities.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • ASPIRE-BioNEST
  • BIRAC
  • Covid-19
  • Hyderabad

Related News

  • Hyderabad: NTPC distributes merit scholarship among 104 students

  • SCR to operate two special trains to clear extra rush

  • Planning to drink a few pegs and drive in Hyd? Be prepared to perform traffic duties

  • Watch: Youngster jumps into Hussain Sagar, rescued

  • Hyderabad: GHMC installs steel portal frame for Shilpa Layout flyover

  • Hyderabad Traffic Police, BITS Pilani tie up to fix ‘black spots’

Latest News

  • Hyderabad Airport wins green airport recognition for fifth time

    21 mins ago
  • Pattana Pragathi in GHMC from June 3

    28 mins ago
  • American Brew Crafts launches Blockbuster beer in a can

    35 mins ago
  • Car with ‘special’ registration plate picks up KTR at London airport

    21 seconds ago
  • Hyderabad police arrest VC of Sarvepalli Radhakrishnan University, Bhopal

    47 mins ago
  • Charmi Jhaveri looks outstanding in a white Saree at the official Kobe PR Ambassador ceremony

    1 hour ago
  • Viral video of Indian-American student getting bullied is raging the internet

    2 hours ago
  • Palle Pragathi, Pattana Pragathi postponed, to be held from June 3

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam